Source: Health Products Regulatory Authority (IE) Revision Year: 2020 Publisher: Wisdom Pharmaceutical Technology Co Limited, Wilton Park House, Wilton Place, Dublin 2, Ireland
Voltfast Sachets 50mg Powder for Oral Solution.
Pharmaceutical Form |
---|
Powder for oral solution. White to light yellow powder for oral solution. |
The active ingredient is potassium [o-[(2,6-dichlorophenyl)-amino]-phenyl-acetate (diclofenac potassium).
One sachet contains 50 mg of diclofenac potassium.
One sachet also contains 50mg aspartame (E951).
For a full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Diclofenac |
Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms. |
List of Excipients |
---|
Potassium hydrogen carbonate |
Sachet consisting of coupled paper/aluminium/polyethylene, hermetically sealed in four directions. Three sachets are packaged in one carton.
Wisdom Pharmaceutical Technology Co Limited, Wilton Park House, Wilton Place, Dublin 2, Ireland
PA2308/001/001
Date of first authorisation: 14 July 2006
Date of last renweal: 25 July 2008
Drug | Countries | |
---|---|---|
VOLTFAST | Ireland, Italy, Malta, Nigeria, New Zealand, Singapore |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.